Hsp90
Showing 1 - 25 of 220
Hidradenitis Suppurativa Trial in Aarhus (RGRN-305, Placebo)
Completed
- Hidradenitis Suppurativa
- RGRN-305
- Placebo
-
Aarhus, DenmarkAarhus University Hospital
Jan 30, 2023
Metastatic or Unresectable Solid Tumor Malignancy Trial in Fort Myers, Oklahoma City, Nashville (Capecitabine, Hsp90 Inhibitor
Completed
- Metastatic or Unresectable Solid Tumor Malignancy
- Capecitabine
- Hsp90 Inhibitor AUY 922
-
Fort Myers, Florida
- +2 more
Feb 15, 2022
Melanoma Trial in Tampa (XL888, Vemurafenib)
Active, not recruiting
- Melanoma
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 18, 2022
Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,
Active, not recruiting
- Colorectal Adenocarcinoma
- +14 more
- XL888
- Pembrolizumab
-
Atlanta, Georgia
- +2 more
Jul 5, 2022
HSP90 in Peripheral Vascular Lesions of Diabetic Atherosclerosis
Completed
- Peripheral Arterial Disease
- non-intervention
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Mar 4, 2021
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- CDK Inhibitor AT7519
- +3 more
-
Washington, District of Columbia
- +5 more
Oct 18, 2022
Recurrent NSCLC, Squamous Cell Lung Cancer, Stage IV NSCLC Trial in Los Angeles (Hsp90 inhibitor AUY922, pemetrexed disodium,
Completed
- Recurrent Non-small Cell Lung Cancer
- +2 more
- Hsp90 inhibitor AUY922
- +3 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Sep 1, 2020
Traitment of Acute Lymphoblastique Leukemia With
Recruiting
- Acute T Lymphoblastic Leukemia (T-ALL)
- Acute B Lymphoblastic Leukemia (B-ALL)
- injection of BEP 800
- Control
-
Dijon, FranceChu Dijon Bourgogne
Jun 19, 2020
Adenocarcinoma of the Lung, NSCLC Trial in Chicago, New York (drug, other, procedure, genetic)
Completed
- Adenocarcinoma of the Lung
- Non-small Cell Lung Cancer
- erlotinib hydrochloride
- +5 more
-
Chicago, Illinois
- +1 more
Aug 27, 2019
Peritoneal Carcinomatosis Trial in Nice (peripheral venous blood samples)
Terminated
- Peritoneal Carcinomatosis
- peripheral venous blood samples
-
Nice, FranceDigestive department - Archet hospital
Aug 30, 2019
Aging Trial (Passive heating)
Not yet recruiting
- Aging
- Passive heating
- (no location specified)
Nov 17, 2022
Aging Trial (Passive heating)
Not yet recruiting
- Aging
- Passive heating
- (no location specified)
Nov 17, 2022
Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)
Recruiting
- Carcinoma
- +18 more
- PEN-866 Sodium
- +3 more
-
Springdale, Arkansas
- +15 more
Feb 16, 2022
Healthy Participants Trial (Acute Maastricht Stress Test (MAST), active condition., Acute Maastricht Stress Test (MAST),
Not yet recruiting
- Healthy Participants
- Acute Maastricht Stress Test (MAST), active condition.
- Acute Maastricht Stress Test (MAST), placebo condition
- (no location specified)
Dec 21, 2022
Lymphoma, Advanced Solid Tumor Trial in Philadelphia (Gamitrinib)
Recruiting
- Lymphoma
- Advanced Solid Tumor
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Feb 2, 2022
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Worldwide (Ganetespib, Paclitaxel)
Terminated
- Epithelial Ovarian Cancer
- +2 more
-
Innsbruck, Austria
- +9 more
Jun 25, 2019
Gastroesophageal Junction Adenocarcinoma, Malignant Tumor of the Cervical Esophagus, Malignant Tumor of the Thoracic Esophagus
Completed
- Gastroesophageal Junction Adenocarcinoma
- +7 more
- Carboplatin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 22, 2019
Cancer Related Fatigue Trial in Stavanger (REBECCA-assisted intervention)
Recruiting
- Cancer Related Fatigue
- REBECCA-assisted intervention
-
Stavanger, Rogaland, NorwayStavanger University Hospital
Nov 6, 2023
Monitoring of Chronic Conditions in Breast Cancer
Recruiting
- Breast Cancer
- Chronic Fatigue Syndrome
-
Stavanger, NorwayHelse Stavanger HF
Oct 19, 2022